CRYPTOCOCCAL ANTIGENEMIA

Clinical trials for CRYPTOCOCCAL ANTIGENEMIA explained in plain language.

Never miss a new study

Get alerted when new CRYPTOCOCCAL ANTIGENEMIA trials appear

Sign up with your email to follow new studies for CRYPTOCOCCAL ANTIGENEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a shorter drug course beat a longer one for a deadly fungal infection?

Disease control Not yet recruiting

This trial is testing whether a 10-week course of fluconazole works as well as the standard 24-week course for people with HIV who have a cryptococcal infection in their blood (antigenemia) but no symptoms. It also compares starting HIV medications right away versus waiting 14 da…

Matched conditions: CRYPTOCOCCAL ANTIGENEMIA

Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC

CRYPTOCOCCAL ANTIGENEMIA

Get alerted when new CRYPTOCOCCAL ANTIGENEMIA trials appear

Could a shorter drug course beat a longer one for a deadly fungal infection?